INdividualised Treatment targets for EldeRly patients using Vildagliptin Add-on or Lone therapy (INTERVAL) study

被引：0
|
作者：
Strain, W. David [1 ]
Lukashevich, V. [2 ]
Kothny, W. [2 ]
Hoellinger, M. -J. [3 ]
Paldanius, P. [3 ]
机构：
[1] Univ Exeter, Sch Med, Exeter EX4 4QJ, Devon, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
891
引用
收藏
页码：S354 / S355
页数：2
相关论文
共 50 条
  • [1] Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
    Strain, W. David
    Lukashevich, Valentina
    Kothny, Wolfgang
    Hoellinger, Marie-Jose
    Paldanius, Paeivi Maria
    LANCET, 2013, 382 (9890): : 409 - 416
  • [2] ECONOMIC EVALUATION OF VILDAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN DIABETES MELLITUS TREATMENT IN CHINA
    Chen, W.
    Zhu, J.
    VALUE IN HEALTH, 2012, 15 (07) : A664 - A664
  • [3] Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients
    Bozek, Andrzej
    Warkocka-Szoltysek, Barbara
    Filipowska-Gronska, Agata
    Jarzab, Jerzy
    JOURNAL OF ASTHMA, 2012, 49 (05) : 530 - 534
  • [4] Outcomes in patients not receiving add-on therapy in the Study on COgnition and Prognosis in the Elderly (SCOPE)
    Zanchetti, A
    Skoog, I
    Elmfeldt, D
    Hofman, A
    Olofsson, B
    Trenkwalder, P
    Lithell, H
    JOURNAL OF HYPERTENSION, 2004, 22 : S150 - S150
  • [5] Outcomes in patients not receiving add-on therapy in the study on cognition and prognosis in the elderly (SCOPE)
    Zanchetti, A
    Skoog, I
    Elmfeldt, D
    Hofman, A
    Olofsson, B
    Trenkwalder, P
    Lithell, H
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 188A - 188A
  • [6] Vildagliptin as add-on therapy to other oral antidiabetics in Japanese patients with type 2 diabetes
    Suzuki, M.
    Hamada, I.
    Odawara, M.
    DIABETOLOGIA, 2012, 55 : S354 - S354
  • [7] Efficacy of ranolazine as add-on therapy for chronic angina in elderly patients
    Chaitman, BR
    Skettino, S
    Parker, JO
    Skopal, J
    Chumakova, G
    Kuch, J
    Wang, W
    Wolff, AA
    CIRCULATION, 2002, 106 (19) : 330 - 330
  • [8] Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
    Pan, C.
    Xing, X.
    Han, P.
    Zheng, S.
    Ma, J.
    Liu, J.
    Lv, X.
    Lu, J.
    Bader, G.
    DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 737 - 744
  • [9] The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization
    Lithell, H
    Hansson, L
    Skoog, I
    Elmfeldt, D
    Hofman, A
    Olofsson, B
    Trenkwalder, P
    Zanchetti, A
    JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1605 - 1612
  • [10] COMPARISON OF VILDAGLIPTIN AS AN ADD-ON THERAPY AND SULFONYLUREA DOSE-INCREASING THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES USING METFORMIN AND SULFONYLUREA
    Hong, A. R.
    Lee, J.
    Ku, E. J.
    Hwangbo, Y.
    Kim, K. M.
    Moon, J. H.
    Choi, S. H.
    Jang, H. C.
    Lim, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S141 - S141
12345